Revolutionary stem cell treatment shows promise for Type 1 diabetes
A new study found that a stem cell treatment called zimislecel helped 10 out of 12 people with severe type 1 diabetes go at least a year without needing insulin shots.
This could be a big step forward for anyone tired of constant injections.
How the study was conducted
Participants got lab-grown islet cells to replace the ones their bodies can't make.
To help these cells work, everyone took immune-suppressing meds.
No one had dangerous low blood sugar episodes, though some did have mild side effects like lower kidney function from the meds.
Importantly, no serious problems were linked directly to zimislecel, so bigger trials are next.
Hope on the horizon for easier diabetes management
If these results hold up in larger studies, stem cell therapy could totally change life for millions living with T1D—no more daily insulin and fewer scary blood sugar swings.
It's early days, but there's real hope on the horizon for easier diabetes management.